AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New cancer vaccine program launched.

Vaccine Weekly

| February 11, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 FEB 11 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur and Aventis Pharma have joined forces to develop a therapeutic cancer vaccine program at a state-of-the-art cancer vaccine laboratory opened earlier this year in Ontario.

The laboratory, located in Toronto, houses Canada's first robotic arm for vaccine production.

The global cancer vaccine program, anchored in Ontario, has enlisted top scientists from around the world, as well as other innovative biotechnology companies located there, to research, develop and market therapeutic vaccines for cancer. The company has committed up to CDN $350 million over 10 years.

In contrast with traditional vaccines, which prevent disease by preparing the immune system for a possible attack later, therapeutic vaccines boost the immune system of people who already have the ...

Related articles from newspapers, magazines, journals, and more
New cancer vaccine program launched.
Newspaper article from: Cancer Vaccine Week February 9, 2004 700+ words
...joined forces to develop a therapeutic cancer vaccine program at a state-of-the-art cancer vaccine laboratory opened earlier this year...for vaccine production. The global cancer vaccine program, anchored in Ontario, has enlisted...
Epimmune Provides Cancer Vaccine Program Update.
Press release article from: PR Newswire October 2, 2001 700+ words
...additional information on its cancer vaccine program including its initial vaccine...forward with a therapeutic lung cancer vaccine candidate and anticipates that...said, "Taking our initial cancer vaccine candidate into the clinic represents...
Corixa Provides Update on Lung Cancer Vaccine Program; Reacquires North...
Press release article from: Business Wire February 4, 2003 700+ words
...commercial rights to the lung cancer vaccine program previously developed in...antigens discovered in its lung cancer vaccine program in all countries previously...research phase of the lung cancer vaccine program, Zambon and Corixa have...
Epimmune Takes Over Cancer Vaccine Program.
Press release article from: PR Newswire November 13, 2000 700+ words
...full responsibility for its cancer vaccine program following Pharmacia Corporation...to continue funding the cancer vaccine program. Accordingly, Pharmacia...the reacquisition of the cancer vaccine program represents a tremendous...
Initial clinical data from GVAX pancreatic cancer vaccine program.
Newspaper article from: Cancer Weekly July 27, 2004 700+ words
...clinical trial of GVAX pancreatic cancer vaccine in patients with inoperable...company's GVAX pancreatic cancer vaccine program. These 2 trials were prompted...to 6 doses of GVAX pancreatic cancer vaccine at 21-day intervals. Cohort...
Cell Genesys Reports Initial Clinical Data From GVAX(R) Pancreatic Cancer...
Press release article from: PR Newswire June 26, 2004 700+ words
...trial of GVAX(R) pancreatic cancer vaccine in patients with inoperable...company's GVAX(R) pancreatic cancer vaccine program. These two trials were prompted...doses of GVAX(R) pancreatic cancer vaccine at 21-day intervals. Cohort...
CORIXA, KIRIN TO COLLABORATE ON CANCER VACCINE PROGRAM.
Magazine article from: BIOWORLD Today Huggett, Brady December 6, 2002 700+ words
Corixa Corp. is looking to the East for a cancer vaccine, signing an agreement with Kirin Brewery Co. Ltd...Australasia using Corixa's Wilms' tumor (WT1) antigen vaccine program. For North America, the companies will share rights...
-GENZYME MOLECULAR ONCOLOGY: GMO options technology to expand cancer vaccine...
Press release article from: M2 Presswire May 28, 1998 700+ words
M2 PRESSWIRE-28 May 1998-GENZYME MOLECULAR ONCOLOGY: GMO options technology to expand cancer vaccine program (C)1994-98 M2 COMMUNICATIONS LTD RDATE:280598 Genzyme Molecular Oncology announced today that it has entered into an agreement...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA